Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998

HIV Medicine

Volumn 7, Issue 3, 2006, Pages 140-145

  Lebouché, Bertrand ^a,b   Yazdanpanah, Y ^a,c,d   Gerard Y ^a   Sissoko, D ^a   Ajana, F ^a   Alcaraz, I ^a   Boitte, P ^e   Cadore B ^e   Mouton, Y ^a  

^a Dron Hospital   (France)

^b HÔTEL DIEU   (France)

^c UNIV LILLE   (France)

^d CNRS   (France)

^e Centre Médical   (France)

Author keywords

Drop out; HIV infection; Loss to follow up; Missingdata; Observational study

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; FOLLOW UP; FRANCE; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SOCIAL ASPECT;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; CASE-CONTROL STUDIES; EMIGRATION AND IMMIGRATION; ETHNIC GROUPS; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HOMOSEXUALITY; HUMANS; INCIDENCE; MALE; ODDS RATIO; PATIENT DROPOUTS; RISK FACTORS; SOCIAL CLASS; TIME FACTORS;

EID: 33644785899     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2006.00357.x     Document Type: Article

References (20)

1. Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860.
2. Hogg RS, O'Shaughnessy MV, Gataric N et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349: 1294.
3. Friedland GH, Williams A. Attaining higher goals in HIV treatment: The central importance of adherence. AIDS 1999; 13 (Suppl. 1): S61-S72.
4. Ioannidis JP, Bassett R, Hughes MD, Volberding PA, Sacks HS, Lau J. Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 22-30.
5. Hunt JR, White E. Retaining and tracking cohort study members. Epidemiol Rev 1998; 20: 57-70.
6. Yazdanpanah Y, Chene G, Losina E et al. Incidence of primary opportunistic infections in two HIV-infected French clinical cohorts. Int J Epidemiol 2001; 30: 864-871.
7. Mocroft A, Vella S, Benfield TL et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352: 1725-1730.
8. Centers for Disease Control and Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. J Am Med Assoc 1993; 269: 729-730.
9. Miller D, Homan S. Determining transition probabilities: Confusion and suggestions. Med Decis Making 1994; 14: 52-58.
10. Hosmer D, Lemshow S. The multiple logistic regression model, In: Hosmer D, Lemshow S. eds. Applied Logistic Regression. New York: John Wiley & Sons, 1989: 25-37.
11. SAS Institute Inc. SAS/SAT Guide for Personal Computers. Cary, NC: SAS Institute, 1993.
12. Marimoutou C, Chene G, Dabis F, Lacoste D, Salamon R and the Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). HIV infection and AIDS in Aquitaine-data obtained over the last ten years with a hospital-based information system 1985-9. Presse Med 1997; 26: 703-710.
13. Bucquet D, Deveau C, Belanger F et al. Multicenter French cohort of adults with HIV infection. Description and course after 4 years of follow-up. Presse Med 1994; 23: 1247-1251
14. Arici C, Ripamonti D, Maggiolo F et al. Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clin Trials 2002; 3: 52-57.
15. Messiah A, Navaline H, Davis-Vogel A, Tobin-Fiore D, Metzger D. Sociodemographic and behavioral characteristics associated with timeliness and retention in a 6-month follow-up study of high-risk injection drug users. Am J Epidemiol 2003; 157: 930-939.
16. Chan ACH, Palepu A, Guh DP et al. HIV-positive injection drug users who leave the hospital against medical advice: The mitigating role of methadone and social support. J Acquir Immune Defic Syndr 2004; 35: 56-59.
17. Deyo R, Inui TS. Dropouts and broken appointments. A literature review and agenda for future research. Med Care 1980; 18: 1146-1157.
18. Bassetti S, Battegay M, Furrer H et al. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? J Acquir Immune Defic Syndr Hum Retrovirol 1999; 21: 114-119.
19. Catz SL, McClure JB, Jones GN et al. Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care 1999; 11: 361-373.
20. Haddow LJ, Edwards SG, Sinka K et al. Patients lost to follow up: experience of an HIV clinic. Sex Transm Infect 2003; 79: 349-350.